-
El Salvador's Bukele puts conditions on early release of gang prisoners
-
US goes on the offensive in central Asia
-
Fire rages at town hall in France's Limoges after protests: authorities
-
Emotional Lions come up short in Champions Cup as tributes paid to Andrews
-
Unstoppable Barca thrash Betis to extend perfect start
-
Diaz dazzles as Bayern batter Leipzig to go top
-
Maresca faces anxious wait over Haaland injury scare
-
Inter move clear at Serie A summit with Bologna win
-
PSG fight back to beat Strasbourg after Dembele penalty miss
-
Liverpool still have 'lots to improve', says match-winner Isak
-
Looting, blazes and clashes in France amid nationwide protests
-
Looters ransack shops during France cost-of-living protests
-
Walsh breaks her own 50 free world short course record
-
Leinster thump Clermont as grieving Lions set for Champions Cup debut
-
Haaland brace extends Man City's winning start in Premier League
-
Haaland stars in Man City win, Liverpool beat Brentford
-
'Special' Ombudsman storms to victory in Champion Stakes
-
Dortmund go top despite Union Berlin stalemate
-
Brazil's right embraces election betting odds amid polls skepticism
-
Venezia upset Napoli for first Serie A win of season
-
Four more Ebola cases detected in Kenya, bringing total to seven
-
Glasgow and Bulls win as grieving Lions set for Champions Cup debut
-
Clashes erupt in France as protesters vow to make government 'tremble'
-
Smiling pope returns to Vatican after cancer surgery
-
Chwalinska downs Swiatek to set up Wuhan final with world number 170 Kartal
-
In-form Atletico scrape late win at Espanyol
-
Chacarra takes lead as McIlroy falls away in Delhi
-
Rabada returns as S.Africa seek to bounce back against Australia
-
Neto double gives Chelsea win marred by Martinez injury
-
Zverev, Medvedev ousted with Spaniards to clash for Shanghai title
-
'Cockroach' party founder released from Indian police custody
-
French protesters clash with police during nationwide demonstrations
-
Nepal floods 'defining moment' for climate action: UN
-
Zelensky says Trump could lift more Russia sanctions
-
Albanian capital sees fifth straight day of violent clashes
-
Jayawardene quits as coach of five-time IPL winners Mumbai
-
Leaders weigh 'huge benefit', risks of AI for global economy
-
World number 170 Kartal battles past Ostapenko to reach Wuhan final
-
Zverev stunned by Davidovich Fokina in Shanghai semi-finals
-
Pope to return to Vatican after cancer surgery
-
France faces day of cost-of-living protests
-
Haze triggers highest-level alert in parts of Southeast Asia
-
Zelensky says Trump waiving sanctions 'rewards' Putin, warns Moscow wants 'blackout' in Ukraine
-
I'd have left Real Madrid if I were Vinicius, says Mourinho
-
Noosha Aubel: vezetői kudarc új kezdet helyett – alkalmas-e Potsdam polgármestere a tisztsége betöltésére?
-
نوشا آوبل: ناکامی در مدیریت بهجای آغازی نو؛ آیا شهردار پوتسدام از عهدهٔ مسئولیتهایش برمیآید؟
-
Нуша Аубел: управленски провал вместо ново начало — на висотата на поста си ли е кметицата на Потсдам?
-
Noosha Aubel: eșec la conducere în locul unui nou început – este primărița Potsdamului la înălțimea funcției sale?
-
Russia hails Trump waiving sanctions as 'historic'
-
Noosha Aubel: falend leiderschap in plaats van een nieuwe start – is de burgemeester van Potsdam berekend op haar taak?
US appeals court temporarily halts mail delivery of abortion pill
A US appeals court on Friday temporarily halted mail delivery of mifepristone, the medication used in the majority of abortions in the United States.
A three-judge panel of the 5th Circuit Court of Appeals delivered the order in a lawsuit brought by the southern state of Louisiana, which has some of the strictest anti-abortion laws in the country, against the Food and Drug Administration (FDA).
The order by the conservative-dominated court requires women seeking abortions anywhere in the United States to obtain mifepristone in person from health clinics, and bans delivery by mail or through a pharmacy.
The appeals court overturned a lower court ruling that allowed mifepristone to continue to be delivered by mail while the FDA conducts a review of its regulations regarding the drug.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and was published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The FDA originally approved mifepristone in 2000. It is the most common method for abortion care in the United States and is also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
Louisiana Attorney General Liz Murrill welcomed the appeals court decision calling it a "Victory for Life!"
"The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other states) through illegal mail-order abortion pills," Murrill said. "Today, that nightmare is over."
- 'Isn't about science' -
Nancy Northup, president and CEO of the Center for Reproductive Rights, condemned the appeals court ruling, which is expected to be appealed to the US Supreme Court.
"This isn't about science -- it's about making abortion as difficult, expensive, and unreachable as possible," Northup said in a statement.
Julia Kaye, an attorney with the American Civil Liberties Union (ACLU), said "anti-abortion politicians have just made it much harder for people everywhere in the country to get a medication that abortion and miscarriage patients have been safely using for more than 25 years."
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
In 2024, the US Supreme Court rejected a bid to restrict mifepristone, ruling that anti-abortion groups and doctors challenging the medication lacked the legal standing to bring the case.
T.Perez--AT